Brief: Evelo Presents New Preclinical Data For Anti-Tumor Effects Of Orally Delivered Microbial Extracellular Vesicles
09/11/2020 13:44
Nov 9 (Reuters) - Evelo Biosciences Inc EVLO.O :
* EVELO BIOSCIENCES PRESENTS NEW PRECLINICAL DATA FOR
ANTI-TUMOR
EFFECTS OF ORALLY DELIVERED MICROBIAL EXTRACELLULAR VESICLES
* EVELO BIOSCIENCES INC - EDP1908 DEMONSTRATES POTENT
ANTI-TUMOR
EFFECTS IN MURINE MODELS OF CANCER
* EVELO BIOSCIENCES INC - ORAL EXTRACELLULAR VESICLES HAVE
POTENTIAL TO BE A COMPLETELY NOVEL MECHANISM OF I/O THERAPY
Source text for Eikon: ID:nGNX1xmMHQ
Further company coverage: EVLO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evelo Biosciences
See all newsU.S. RESEARCH ROUNDUP- Evelo Biosciences, Nkarta, O'Reilly Automotive
U.S. STOCKS ON THE MOVE-DXC Technology, Nvidia, Lisata Therapeutics
Evelo Bio slumps after skin disease drug fails in mid-stage study
U.S. STOCKS ON THE MOVE-Nvidia, Westlake, North American steel companies
U.S. STOCKS ON THE MOVE-TMC, PayPal, TOMI